A major objective of surgical management of coronary artery disease is improvement in quality of life. This objective appears to have been fulfilled by surgery, at least early, in most studies comparing medically treated patients with patients undergoing surgery. Dorovenis, S and B Weiner. Pharmacologic Prophylaxis of Supraventricular Tachyarrhythmias After Coronary Artery Bypass. Coronary bypass surgery is an accepted treatment for patients with coronary artery disease.
Perioperative morbidity includes development of supraventricular arrhythmias.
To prevent this, prophylactic administration of drugs such as calcium channel blockers, digoxin, and b-blockers have been advised. The Pharmacist's Perspective. The structured care plan for a coronary artery bypass surgery defines what is expected of the pharmacist, states when such responsibilities are to be provided, and serves as a documentation tool for such accountabilities. To fulfill the specific teaching responsibility documented in the structured plan, a patient-medication discharge computer program has been developed. Drug Interactions with Warfarin.